000728:SZSEGuoyuan Securities Company Limited Analysis
Data as of 2026-06-14 - not real-time
CN¥6.97
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Guoyuan Securities is trading at CNY 6.97, well below its 20‑day (CNY 7.05), 50‑day (CNY 7.33) and 200‑day (CNY 8.25) moving averages, signaling a bearish technical backdrop. The RSI sits near 44, hinting at a neutral‑to‑slightly‑oversold condition, while the MACD histogram is negative and the MACD line trails its signal, reinforcing downside momentum. Volume is on a decreasing trend despite still exceeding the 10‑day average, and volatility over the past 30 days is elevated at roughly 23 %, suggesting price swings may persist.
Fundamentally, the company’s revenue has contracted by 12.8 % year‑over‑year, yet it maintains robust gross (54 %) and operating (50 %) margins, delivering a healthy profit margin of 38 %. Valuation metrics are attractive: a trailing P/E of 13.2 versus the industry average of 16.8, and a P/B of 0.78, indicating the stock is priced below book value. The dividend yield of 2.58 % with a modest payout ratio of 34 % appears sustainable given solid operating cash flow, though the balance sheet is leveraged (debt‑to‑equity ~267 %). A DCF‑derived fair value of CNY 28.9 and analyst target prices near CNY 10 suggest considerable upside potential, albeit tempered by high leverage and recent earnings decline.
Fundamentally, the company’s revenue has contracted by 12.8 % year‑over‑year, yet it maintains robust gross (54 %) and operating (50 %) margins, delivering a healthy profit margin of 38 %. Valuation metrics are attractive: a trailing P/E of 13.2 versus the industry average of 16.8, and a P/B of 0.78, indicating the stock is priced below book value. The dividend yield of 2.58 % with a modest payout ratio of 34 % appears sustainable given solid operating cash flow, though the balance sheet is leveraged (debt‑to‑equity ~267 %). A DCF‑derived fair value of CNY 28.9 and analyst target prices near CNY 10 suggest considerable upside potential, albeit tempered by high leverage and recent earnings decline.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price hovering near the technical support level of CNY 6.66
- bearish MACD signal and decreasing trading volume
- valuation upside but high leverage raises downside risk
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- substantial valuation gap to DCF fair value and analyst targets
- stable dividend yield with a comfortable payout ratio
- potential earnings recovery as margins remain strong
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value indicates significant long‑run upside
- consistent dividend policy supports total return
- low beta reduces sensitivity to broader market swings
Key Metrics & Analysis
Financial Health
Revenue Growth-12.80%
Profit Margin38.59%
P/E Ratio13.2
ROE6.12%
ROA1.23%
Debt/Equity267.33
P/B Ratio0.8
Op. Cash FlowCN¥15.2B
Industry P/E16.8
Technical Analysis
TrendBearish
RSI44.0
SupportCN¥6.66
ResistanceCN¥7.66
MA 20CN¥7.05
MA 50CN¥7.33
MA 200CN¥8.25
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair ValueCN¥28.88
Target PriceCN¥9.90
Upside/Downside42.04%
GradeUndervalued
TypeValue
Dividend Yield2.58%
Risk Assessment
Beta0.45
Volatility22.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.